BIOMARIN PHARMACEUTICAL INC

Q2 2025 13F Holders

CUSIP
09061GAK7
Type
Debt
Class
NOTE 1.250% 5/1
Num filings
69
Total reported value, excl. options
$525 M
Manager Report Date Value ($000) Principal Option Type